(MENAFN- GlobeNewsWire - Nasdaq) Opportunities center on real-time, high-throughput drug discovery and diagnostics, driven by SPR/BLI advances, AI analytics, CRO adoption, improved sensitivity and Asian localization.Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Label-Free Array Systems Market Report 2026" has been added to ResearchAndMarkets.com's offering.
The global label-free array systems market is experiencing strong growth, supported by expanding pharmaceutical research and development, increased investment in life sciences, and rising demand for real-time molecular interaction analysis. The market is projected to grow from $1.48 billion in 2025 to $1.59 billion in 2026, representing a compound annual growth rate (CAGR) of 7.6%.
Historical market growth has been driven by the expansion of academic and research institutions, increased pharmaceutical R&D activity, and broader adoption of biosensor technologies. Although limited platform availability and continued reliance on conventional labeling methods previously constrained adoption, ongoing technological advances are helping label-free detection gain traction across research and commercial laboratories.
The label-free array systems market is forecast to reach $2.1 billion by 2030, expanding at a CAGR of 7.2%. Key growth factors include advances in surface plasmon resonance and bio-layer interferometry, increased adoption by contract research organizations, and growing demand for automated, high-throughput screening systems. The integration of artificial intelligence and big data analytics is also expected to strengthen data interpretation, improve workflow efficiency, and support more advanced kinetics and affinity mapping.
Major label-free array systems market trends include increased use of real-time molecular interaction analysis, growing adoption in drug discovery and protein-protein interaction studies, and continued improvements in assay sensitivity and accuracy. High-throughput screening capabilities are becoming increasingly important as pharmaceutical and biotechnology organizations seek to analyze larger volumes of biological data while accelerating therapeutic development.
The rising prevalence of lifestyle-related chronic diseases is expected to support market expansion. More sedentary lifestyles, poor dietary habits, physical inactivity, smoking, and excessive alcohol consumption are contributing to adverse health outcomes and increasing the need for earlier detection, risk assessment, and personalized prevention strategies. Label-free array platforms support these objectives through real-time, high-throughput biomolecular analysis.
According to information reported by the World Health Organization in May 2025, approximately 2.5 billion adults aged 18 and older were overweight in 2022, including more than 890 million people living with obesity. The organization also projected that nearly 35 million children under five could be affected by overweight conditions by 2032. This growing health burden is increasing demand for advanced research and diagnostic technologies that can support disease investigation and therapeutic development.
Innovation remains a central competitive strategy in the label-free array systems market. In February 2024, SPOC Proteomics Inc. introduced customizable SPOC protein biosensor chips capable of real-time, label-free detection across as many as 1,000 fully folded proteins on a compact 1.5 cm surface plasmon resonance chip. The platform synthesizes proteins directly from DNA in nanoliter-scale wells while capturing and purifying them on the sensor surface.
This approach removes the need for conventional recombinant protein production and may reduce associated costs by 10 to 100 times compared with traditional methods. The chips also generate large-scale qualitative, quantitative, and kinetic datasets, supporting their use in high-throughput proteomic research and advanced drug discovery workflows.
Strategic acquisitions are further shaping the market. In January 2023, Charles River Laboratories International Inc. acquired SAMDI Tech Inc. for $50 million. The transaction expanded Charles River's drug discovery capabilities by integrating its scientific expertise with SAMDI Tech's mass spectrometry-based, label-free screening technology.
North America was the largest region in the label-free array systems market in 2025, while Asia-Pacific is expected to record the fastest growth during the forecast period. The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries assessed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Markets Covered:
1) By Technology: Surface Plasmon Resonance; Bio Layer Interferometry; Cellular Dielectric Spectroscopy; Other Technologies
2) By Accessories: Sensor Chips; Reagents; Consumables; Other Accessories
3) By Application: Drug Discovery; Protein-Protein Interactions; Receptor Ligand Assays; Thermodynamics; Kinetics Or Affinity Mapping; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Surface Plasmon Resonance: Imaging SPR; SPR Microscopy; Multi-Parametric SPR; Localized SPR
2) By Bio Layer Interferometry: Fiber Optic-Based BLI; Plate-Based BLI; High-Throughput BLI Systems
3) By Cellular Dielectric Spectroscopy: Real-Time Impedance-Based Systems; Multi-Well Plate CDS Platforms; Label-Free Cytotoxicity Assays
4) By Other Technologies: Microcantilever-Based Systems; Optical Waveguide Grating Sensors; Quartz Crystal Microbalance (QCM); Field-Effect Transistor (FET)-Based Biosensors
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment